Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Vandana Singh

Cooper Companies' Q1 Earnings Surpass Expectations, Lifts FY22 Outlook

Cooper Companies Inc's (NYSE:COOQ1 FY22 revenues increased 16% Y/Y to $787.2 million, up 19% in constant currency and 13% organically, beating the consensus of $744.34 million.

  • The CooperVision (CVI) segment revenue increased 11% to $561.5 million, and CooperSurgical (CSI) revenue up 30% to $225.7 million.
  • Non-GAAP EPS of $3.24, up 2% Y/Y, beat the consensus of $3.10.
  • The adjusted gross margin was 67%, down from 68% last year, driven primarily by currency. Adjusted operating margin compressed to 25% from 27% in last year's first quarter, driven primarily by currency and higher investing.
  • Net debt outstanding at quarter-end was $2.9 billion due to the acquisition of Generate Life Sciences. Adjusted leverage ratio was 2.71x.
  • Related: CooperCompanies Scoops Up Cook Medical's Reproductive Health Business For $875M.
  • Cash provided by operations of $166.0 million offset by capital expenditures of $57.1 million resulted in a free cash flow of $108.9 million.
  • Guidance: Cooper Companies expects FY22 sales of $3.261 billion - $3.329 billion (organic growth of 6.5% to 8.5%), compared to the consensus of $3.29 billion.
  • Earlier, the company guided sales of $3.03 billion - $3.09 billion.
  • The outlook includes CVI segment revenue $2.22 billion - $2.26 billion and CSI segment sales of $1.04 billion - $1.06 billion.
  • For FY22, the company expects adjusted EPS of $13.70 - $14.20, versus the consensus of $14.36 and prior guidance of $13.60 - $14.00.
  • Price Action: COO shares closed 0.34% higher at $417.14 on Thursday.
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.